Q2 2024 Everest Medicines Ltd Earnings Call Transcript
Good morning and good evening. Welcome to Everest Medicines 2024 mid-year financial results conference call. Please be advised that today's conference is being recorded. (Operator Instructions)
And finally, I would like to hand conference over to your speaker today, Ms. Leah Liu, please go ahead.
Hi. Good morning, everyone. I'm Leah Liu from Everest Medicines. Thank you, operator. And everyone, welcome to our 2024 first half-year financial results conference call. Joining us today are Mr. Rogers Luo, our Chief Executive Officer; Mr. Ian Woo, President and CFO, Dr. Jennifer Yang, our Chief Scientific Officer; Sandra Zeng, our Chief Medical Officer; and Rico Liang, our Chief Product Officer.
Before we get started, I'd like to remind you that the speakers on this conference call may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |